Hong Kong Pharmaceuticals Stock News

Investors pushed Sichuan Kelun-Biotech Biopharmaceutical up to HK$542.5 by Monday’s close, after a strong run over the past quarter, yet the fresh numbers tell a more complicated story than the price chart alone. The emotional hook is clear: H1 2026 swung back to profit with basic earnings per share of CN¥1.66 and net income of CN¥388.01m, a sharp contrast to the losses booked through 2025. The question is whether this return to the black justifies the rich P/B multiple and elevated...

The market has treated Wanguo Gold Group like a high growth gold producer, and the recent share price strength reflects that confidence. After a strong 30 day run into the H1 2026 release, investors came in expecting proof that earnings power still justifies a premium P/E tag versus the wider Hong Kong metals and mining sector. The headline did not disappoint on raw profitability. Net income for the half year was C¥905.33 million on revenue of C¥1,863.33 million, which keeps margins looking...

China Lilang stock closed at HK$3.11, soft after a week and month in which the share price slipped around 8% to 10%. Yet the earnings story that landed after the bell is less about the latest tick in the chart and more about what the valuation now implies. The headline this season is the gap between profit power and price. Trailing 12 month earnings sit against a P/E of 6.7x, while a discounted cash flow estimate of HK$5.39 suggests investors are still treating the menswear group with caution...

Tenfu (Cayman) Holdings stock has barely budged in the past month, yet the latest half year numbers quietly reshaped the story. The market is still pricing the tea producer on a relatively rich P/E of 20.5x compared with Hong Kong food peers, even as reported earnings over the past five years have moved lower. The headline from this earnings release is that margins in the last 12 months improved to 9.4%, while profit growth over that same period was only 1.8%. The tension between a higher...

Yue Yuen Industrial (Holdings) earnings move into focus Yue Yuen Industrial (Holdings) (SEHK:551) is back in focus after reporting half year 2026 earnings that showed lower sales and a sharp drop in net income, a combination many investors will watch closely. See our latest analysis for Yue Yuen Industrial (Holdings). The half year 2026 results come after a period where Yue Yuen Industrial (Holdings)' share price fell 14.4% year to date, while the 3 year total shareholder return of 77.61%...

Sands China (SEHK:1928) drew fresh attention on 14 August after releasing its interim 2026 results and declaring an ordinary interim dividend of HK$0.50 per share for the half year. See our latest analysis for Sands China. Sands China shares closed at HK$14.51, with a 1 month share price return of 10.93% but year to date share price performance still down 27.38%, and a 5 year total shareholder return down 30.06%. This suggests recent momentum is improving from a weak longer term base as...

Chervon Holdings interim results draw fresh attention Chervon Holdings (SEHK:2285) has become a focus for investors after releasing interim earnings on 17 August 2026. The company reported higher sales, net income and earnings per share for the half year to 30 June. See our latest analysis for Chervon Holdings. The interim results and recent share buyback have arrived alongside a 25.97% 90-day share price return and a 10.70% 30-day share price return, while the 1-year total shareholder return...

Grand Pharmaceutical Group (SEHK:512) has drawn investor attention after announcing that its radionuclide drug candidate GPN01530-2 for solid tumor diagnosis has received Fast Track Designation from the United States Food and Drug Administration. See our latest analysis for Grand Pharmaceutical Group. The FDA Fast Track news has arrived during a mixed period for Grand Pharmaceutical Group's stock. The latest share price of HK$5.345 comes after a 1-day share price return of 2.00%, while the...

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

Axera Semiconductor Co., LTD. ( HKG:600 ) is possibly approaching a major achievement in its business, so we would like...

Just because a business does not make any money, does not mean that the stock will go down. For example, although...

Samsonite Group (SEHK:1910) is in focus after half year 2026 results showed sales of US$1,680.6 million with lower net income, alongside guidance that third quarter constant currency sales growth should remain broadly similar to the second quarter. See our latest analysis for Samsonite Group. The latest guidance appears to have done little to lift sentiment, with Samsonite Group’s 1-day share price return of 1.44% only partly offsetting a year to date share price decline of 32.95%, while the...

Tencent earnings, AI spending and what they mean for investors Tencent Holdings (SEHK:700) has moved back into focus after second quarter 2026 earnings, continued heavy investment in artificial intelligence and the wider rollout of its Hy3 model put profitability and long term growth plans under scrutiny. See our latest analysis for Tencent Holdings. Tencent Holdings shares closed at HK$446.4, with the stock posting a 1-day share price return of 1.45% after earnings. It remains down 28.35% on...

Why Ma Chengdong’s Appointment Matters For Jinhai Medical Technology Jinhai Medical Technology (SEHK:2225) has appointed industry veteran Ma Chengdong as chief marketing officer for an initial one year term, with responsibilities spanning marketing strategy, market access and commercialisation of medical devices. For you as an investor, this kind of leadership change is less about the job title and more about what it could mean for how the company positions and sells its products. The...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

In recent months, Asian markets have experienced a mix of volatility and opportunity, with key indices reflecting a dynamic economic landscape influenced by global inflation trends and geopolitical tensions. As investors navigate these conditions, the search for promising small-cap stocks becomes crucial, particularly those that exhibit strong fundamentals and potential for growth amid insider activity.

Onewo Inc. ( HKG:2602 ) came out with its half-yearly results last week, and we wanted to see how the business is...

A blockbuster SpaceX IPO at more than US$1.8t has suddenly made the sleepy IPO market feel interesting again. Fresh talk of large AI listings and heavier spending on data centres is putting capital markets firms back in focus, and investors do not want to be late if deal fees recover meaningfully. This article walks through 3 stocks exposed to this IPO revival story and what that could mean for your portfolio. The three stocks covered below are only a starting sample, since the full screen...

Xiaomi (SEHK:1810) stock has drawn attention after recent trading performance showed mixed returns. The share price is around HK$25.88, with the company’s different business segments giving investors several angles to assess its current valuation. See our latest analysis for Xiaomi. Recent trading in Xiaomi reflects pressure on the share price over 2026, with the 90 day share price return down 15.54% and the year to date share price return down 35.75%, even though the 3 year total shareholder...

Morimatsu International Holdings (SEHK:2155) has guided for a consolidated loss of RMB150,000,000 to RMB180,000,000 for the first half of 2026, compared with a profit in the same period last year. See our latest analysis for Morimatsu International Holdings. Morimatsu International Holdings’ HK$7.64 share price has had mixed momentum, with a 30 day share price return of 5.23% but a year to date share price decline of 16.59%. The 3 year total shareholder return of 55.45% contrasts with a 1...

Pacific Basin Shipping (SEHK:2343) has drawn attention after reporting half year sales of US$1,105.48 million and net income of US$105.05 million, alongside declaring an ordinary interim dividend of HK$0.155 per share. See our latest analysis for Pacific Basin Shipping. The latest earnings, dividend and buyback updates come after a strong run in Pacific Basin Shipping's stock, with a 69.07% year to date share price return and an 84.64% total shareholder return over one year, suggesting...

China Petroleum & Chemical stock reaction to new PVA capacity China Petroleum & Chemical (SEHK:386) has completed commissioning of a specialty polyvinyl alcohol facility at Chongqing SVW Chemical, creating the world’s largest single site for high end PVA production capacity. The new 50,000 metric ton unit takes total site capacity to 210,000 metric tons a year and supports materials used in photovoltaics, electronics, optical films and pharmaceuticals, with first shipments already sent to...

With rate hike expectations cooling after softer U.S. data and the dollar slipping from recent highs, attention is swinging back to assets that many investors treat as potential hedges when policy and currency trends start to shift. That mix of weaker retail sales, firmer global equities and a softer dollar is creating fresh fear of missing out for anyone underexposed to these themes. This article walks through three stocks from a Gold and Precious-Metals Equity Hedges screener that appear...